Insider trades
Open-market buys and sales that US company officers, directors and 10% owners file, newest filing first.
| Trade type | ||||||||
|---|---|---|---|---|---|---|---|---|
Grygiel Nancy A.SVP & Cco | AmgenAMGN | Open-market sale | 05/04 | 05/05 | 1,237 sh | $323.73 | $400,454.01 | −15.0% |
AmgenAMGN | Open-market sale | 02/26 | 03/02 | 54,792 sh2 trades | $379.12avg. | $20,772,743.04 | −41.7% | |
Matthew C. BuschVP, Finance & CAO | AmgenAMGN | Open-market sale | 02/19 | 02/20 | 1,000 sh | $375.79 | $375,790 | −22.6% |
SVP & Cco | AmgenAMGN | Open-market sale | 25/11/20 | 25/11/21 | 3,139 sh2 trades | $337.26avg. | $1,058,659.14 | −30.3% |
Gordon MurdoEVP, Global Commercial Ops | AmgenAMGN | Open-market sale | 25/11/12 | 25/11/13 | 6,879 sh | $336.83 | $2,317,053.57 | −14.1% |
Rachna KhoslaSVP, Business Development | AmgenAMGN | Open-market sale | 25/11/12 | 25/11/13 | 890 sh | $336.24 | $299,253.6 | −11.2% |
Grygiel Nancy A.SVP & Cco | AmgenAMGN | Open-market sale | 25/08/20 | 25/08/22 | 1,267 sh | $296.99 | $376,286.33 | −14.9% |
Rachna KhoslaSVP, Business Development | AmgenAMGN | Open-market sale | 25/06/05 | 25/06/06 | 1,500 sh | $289.68 | $434,520 | −15.5% |
Matthew C. BuschVP, Finance & CAO | AmgenAMGN | Open-market sale | 25/05/02 | 25/05/06 | 1,000 sh | $279.69 | $279,690 | −19.9% |
AmgenAMGN | Open-market sale | 25/02/19–25/02/21 | 25/02/21 | 33,936 sh2 trades | $301.56avg. | $10,233,738.42 | −47.9% | |
Santos EstebanEVP, Operations | AmgenAMGN | Open-market sale | 25/02/19 | 25/02/21 | 8,711 sh | $292.84 | $2,550,929.24 | −10.9% |
SVP, Human Resources | AmgenAMGN | Open-market sale | 25/02/18–25/02/19 | 25/02/20 | 2,024 sh2 trades | $293.45avg. | $593,939.76 | −19.2% |
Gordon MurdoEVP, Global Commercial Ops | AmgenAMGN | Open-market sale | 25/02/11 | 25/02/13 | 8,771 sh | $294.79 | $2,585,603.09 | −16.6% |
Graham Jonathan P.EVP & Gen. Counsel & Secy | AmgenAMGN | Open-market sale | 25/02/07 | 25/02/10 | 25,045 sh | $293.12 | $7,341,190.4 | −46.4% |
Grygiel Nancy A.SVP & Cco | AmgenAMGN | Open-market sale | 25/02/05 | 25/02/06 | 1,589 sh | $304.47 | $483,802.83 | −18.1% |
Grygiel Nancy A.SVP & Cco | AmgenAMGN | Open-market sale | 24/05/03 | 24/05/03 | 2,117 sh | $313.09 | $662,811.53 | −17.6% |
Grygiel Nancy A.SVP & Cco | AmgenAMGN | Open-market sale | 23/12/04 | 23/12/04 | 2,096 sh | $273.03 | $572,270.88 | −16.2% |
Graham Jonathan P.EVP, Gen. Counsel & Secy | AmgenAMGN | Open-market sale | 23/11/08 | 23/11/13 | 10,000 sh | $272.81 | $2,728,100 | −26.3% |
Gordon MurdoEVP, Global Commercial Ops | AmgenAMGN | Open-market sale | 23/08/10 | 23/08/11 | 9,558 sh | $262.43 | $2,508,305.94 | −17.7% |
